Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
65.20
+3.77 (6.14%)
At close: Mar 6, 2026, 4:00 PM EST
66.43
+1.23 (1.89%)
After-hours: Mar 6, 2026, 6:27 PM EST
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $2.82 billion as of March 6, 2026. Its market cap has increased by 301.76% in one year.
Market Cap
2.82B
Enterprise Value
2.26B
1-Year Change
301.76%
Ranking
Category
Stock Price
$65.20
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $2.82B, an increase of 1,628.98%. That is a compound annual growth rate of 215.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.82B | 59.49% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 3.12B |
| Edgewise Therapeutics | 2.98B |
| Arcutis Biotherapeutics | 2.98B |
| Catalyst Pharmaceuticals | 2.96B |
| IDEAYA Biosciences | 2.91B |
| Viridian Therapeutics | 2.90B |
| Vera Therapeutics | 2.79B |
| Arcus Biosciences | 2.77B |